Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN)

SCAN is a global assessment to be launched worldwide in September 2019

The survey aims to measure access to diagnostics and treatments for neuroendocrine cancer patients around the world from the perspective of NET patients and healthcare professionals.

It is to be conducted:

  • among NET patients, general practitioners and NET specialists
  • in 10+ languages
  • by a self-administered online questionnaire
  • less than 15 minutes to complete

SCAN measures:

  • access to NET diagnostics
  • access to NET treatments
  • financial burden for NET patients
  • awareness of clinical trials
  • quality of communication with medical teams